Surveillance for Leishmaniasis Skin Lesions in Mali
Active Surveillance for Cutaneous Leishmaniasis in Mali
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Listed as NCT00344084, this observational or N/A phase trial focuses on Cutaneous Leishmaniasis and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 20 times since 2006, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
20 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2019 — Jan 2021 [monthly]
Completed
-
Nov 2019 — Dec 2019 [monthly]
Completed
▶ Show 15 earlier versions
-
Sep 2019 — Nov 2019 [monthly]
Completed
-
Aug 2019 — Sep 2019 [monthly]
Completed
-
Jun 2019 — Aug 2019 [monthly]
Completed
-
May 2019 — Jun 2019 [monthly]
Completed
-
Feb 2019 — May 2019 [monthly]
Completed
-
Jan 2019 — Feb 2019 [monthly]
Completed
-
Nov 2018 — Jan 2019 [monthly]
Completed
-
Oct 2018 — Nov 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bamako, Mali